Literature DB >> 16362349

[The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].

R Siegel1, R Linse, B Rau.   

Abstract

Necrolytic migratory erythema (NME) is a rare paraneoplastic dermatologic condition. Its underlying cause is usually a pancreatic islet cell tumour with marked glucagon secretion. The glucagonoma syndrome is characterised by pancreatic neuroendocrine neoplasm, NME, and diabetes mellitus. We present a case of glucagonoma syndrome in a 58-year-old woman with a history of recurrent cutaneous manifestations who was referred for surgical resection of a pancreatic neoplasm after the NME was finally diagnosed. We discuss diagnostic methods, differential diagnosis, and therapeutic management of this disease.

Entities:  

Mesh:

Year:  2006        PMID: 16362349     DOI: 10.1007/s00104-005-1122-y

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  7 in total

1.  Histologic variation in the skin lesions of the glucagonoma syndrome.

Authors:  S M Kheir; E F Omura; W E Grizzle; G A Herrera; I Lee
Journal:  Am J Surg Pathol       Date:  1986-07       Impact factor: 6.394

2.  A glucagonoma syndrome.

Authors:  C N Mallinson; S R Bloom; A P Warin; P R Salmon; B Cox
Journal:  Lancet       Date:  1974-07-06       Impact factor: 79.321

3.  Necrolytic migratory erythema with carcinoma of the pancreas.

Authors:  D S Wilkinson
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1973

Review 4.  The glucagonoma syndrome: a review of its features and discussion of new perspectives.

Authors:  M A Chastain
Journal:  Am J Med Sci       Date:  2001-05       Impact factor: 2.378

Review 5.  Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.

Authors:  A Rosenbaum; B Flourie; S Chagnon; M Blery; R Modigliani
Journal:  Digestion       Date:  1989       Impact factor: 3.216

6.  Necrolytic migratory erythema: clinicopathologic study of 13 cases.

Authors:  Ramon M Pujol; Chin-Yao Eric Wang; Rokea A el-Azhary; W P Daniel Su; Lawrence E Gibson; Arnold L Schroeter
Journal:  Int J Dermatol       Date:  2004-01       Impact factor: 2.736

7.  Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.

Authors:  A F Altimari; N Bhoopalam; T O'Dorsio; C L Lange; L Sandberg; R A Prinz
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.